We observed (pooled) frequencies of abnormal CSF-Aβ42 in 46.3%, abnormal CSF-tau in 25.7%, and abnormal CSF-ptau181 in 40.4% of all SCD patients. This evidence concerns the gene MAPT and Schnyder corneal dystrophy.